Medtronic Sigma, Vitatron Collection II Pacemaker Launch Expected Shortly
This article was originally published in The Gray Sheet
Executive Summary
Medtronic expects to begin shipments of the Sigma line of pacemakers in early September, a move that will trigger a phase-out process for its Prodigy, Preva and Prevail bradycardia devices, the company says.
You may also be interested in...
Vitatron Pacing Line Could Hit U.S. In 12 Months Following European Release
U.S. release of 14 Vitatron pacemaker models is expected over the next 12-15 months, the Medtronic subsidiary said following the April 21 launch of the devices in European markets.
Medtronic's International Release Of Sigma Line Balances Pacing Offerings
Medtronic is filling out its pacemaker offerings with the international roll-out of its Sigma line of "basic" pacemakers in order to meet "the various and economic needs of patients around the world," the company announced Feb. 11. Shipments of the new line began in late January.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.